Mizuho Downgrades Life Tech, Thermo Fisher Amid Concerns Over Academic Spending | GenomeWeb

NEW YORK (GenomeWeb News) – Mizuho Securities today downgraded Life Technologies and Thermo Fisher Scientific on concerns about an uncertain academic spending environment.

In a research note, Peter Lawson downgraded both firms to Neutral from Buy. He lowered his price target for Life Tech to $45 from $52 and trimmed the price target for Thermo Fisher to $55 from $65.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.